Elevated MYC activity is well known to promote glutamine metabolism in the context of cancer by transcriptionally upregulating several glutamine transporters (including Slc1A5) and glutaminase (Gls) (Gao et al., 2009; Wise et al., 2008). This evidence concerns the gene GLS and cancer.